Pred Forte (Prednisolone Acetate Ophthalmic) - Summary

PRED FORTE SUMMARY

PRED FORTE^®(prednisolone acetate ophthalmic suspension, USP) 1%

PRED FORTE^® (prednisolone acetate ophthalmic suspension, USP) 1% is a topical anti-inflammatory agent for ophthalmic use.

PRED FORTE^® is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.

See all Pred Forte indications & dosage >>

PRED FORTE NEWS HIGHLIGHTS

Published Studies Related to Pred Forte (Prednisolone Ophthalmic)

Efficacy of methylprednisolone injected into the masseter muscle following the surgical extraction of impacted lower third molars. [2008.03]

Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study. [2008.02]

Clinical comparison of two topical prednisolone acetate 1% formulations in reducing inflammation after cataract surgery. [2007.10]

High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. [2007.09]

Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy. [2007.09]

more >>

Clinical Trials Related to Pred Forte (Prednisolone Ophthalmic)

Prednisone Timed-Release Tablet (TRT) Study: TRT Formulation of Prednisone Compared to Standard Prednisone in Patients With Rheumatoid Arthritis [Completed]

Prednisone-Placebo vs Prednisone-Valacyclovir in Bell´s Palsy [Completed]

A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte [Completed]

Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma [Terminated]

Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease [Completed]

more >>